Use of Reduced-Dose Periarticular Injection for Pain Management in Simultaneous Bilateral Total Knee Arthroplasty
Journal of Arthroplasty, 06/12/2012
Koh IJ et al. – No patient experienced a serious drug–related adverse effect or wound complication. Blood levels of ropivacaine were observed to be lower than a toxic level throughout the monitored period in all patients examined. Patients in the reduced–dose group experienced less pain during the night of operation, but a similar pain level at postoperative day 1.



